Target intelligence / Profile preview

Trigeminal nerve excitable membrane

Molecular classification
Ion channel, Voltage-gated sodium channel, Membrane protein complex
01

Overview

The excitable membrane of trigeminal nerve fibers refers to the specialized axonal surface of the fifth cranial nerve, which is responsible for transmitting sensory and nociceptive information from the face to the brainstem [1]. This membrane's physiological function is primarily governed by the distribution and activity of voltage-gated sodium channels, which facilitate the rapid influx of sodium ions required for action potential generation and propagation [2]. In pathological states such as trigeminal neuralgia, these membranes often exhibit hyper-excitability or ephaptic transmission, frequently resulting from focal demyelination caused by vascular compression [1, 3]. Pharmacological management of these conditions typically involves the use of sodium channel blockers, most notably carbamazepine, which bind to the inactivated state of the channels within the membrane to suppress ectopic discharges [2, 4]. By stabilizing these excitable membranes and preventing high-frequency repetitive firing, these therapeutic agents effectively reduce the paroxysmal pain characteristic of trigeminal nerve disorders [1, 4]. Consequently, the modulation of ion channel conductance within this membrane is a cornerstone of treatment for neuropathic facial pain [1].

Other names
Excitable membrane of trigeminal nerve fibersTrigeminal axonal membraneTrigeminal nerve membrane
02

Mechanism of action

Stabilization of voltage-gated sodium channels in the inactivated state, thereby reducing the excitability of the nerve membrane and inhibiting the propagation of high-frequency pain impulses.

03

Biological functions

Action potential propagationSensory transductionNociceptionSignal transduction
04

Disease associations

Trigeminal neuralgiaNeuropathic painFacial pain
05

Safety considerations

Stevens-Johnson Syndrome (SJS)Toxic Epidermal Necrolysis (TEN)Aplastic anemiaHyponatremiaAtaxiaDizziness
06

Interacting drugs

Carbamazepine

4 more in the full profile.

07

Biomarkers

HLA-B*15:02 allele (for carbamazepine-induced SJS/TEN risk)

Beyond the preview

Go deeper on Trigeminal nerve excitable membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trigeminal nerve excitable membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call